Comments
Loading...
Boston Scientific Stock Guidance | NYSE:BSX | Benzinga
Boston Scientific issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/23/2025 | BSX | Boston Scientific | Q2 | 2025 | $0.71 | $0.73 | $0.71 | $4.84B | $4.92B | $4.78B | Get Alert |
| 04/23/2025 | BSX | Boston Scientific | FY | 2025 | $2.87 | $2.94 | $2.86 | $19.26B | $19.59B | $19.13B | Get Alert |
| 02/05/2025 | BSX | Boston Scientific | Q1 | 2025 | $0.66 | $0.68 | $0.65 | $4.51B | $4.59B | $4.45B | Get Alert |
| 02/05/2025 | BSX | Boston Scientific | FY | 2025 | $2.80 | $2.87 | $2.81 | $18.84B | $19.18B | $18.79B | Get Alert |
| 10/23/2024 | BSX | Boston Scientific | Q4 | 2024 | $0.64 | $0.66 | $0.64 | $4.34B | $4.41B | $4.28B | Get Alert |
| 10/23/2024 | BSX | Boston Scientific | FY | 2024 | $2.45 | $2.47 | $2.41 | $16.59B | $16.59B | $16.29B | Get Alert |
| 07/24/2024 | BSX | Boston Scientific | Q3 | 2024 | $0.57 | $0.59 | $0.57 | $3.99B | $4.06B | $3.96B | Get Alert |
| 07/24/2024 | BSX | Boston Scientific | FY | 2024 | $2.38 | $2.42 | $2.33 | $16.16B | $16.30B | $16.00B | Get Alert |
| 04/24/2024 | BSX | Boston Scientific | FY | 2024 | $2.29 | $2.34 | $2.25 | $15.81B | $16.09B | $15.58B | Get Alert |
| 04/24/2024 | BSX | Boston Scientific | Q2 | 2024 | $0.57 | $0.59 | $0.56 | $3.98B | $4.05B | $3.93B | Get Alert |
| 01/31/2024 | BSX | Boston Scientific | FY | 2024 | $2.23 | $2.27 | $2.24 | $15.45B | $15.59B | $15.35B | Get Alert |
| 01/31/2024 | BSX | Boston Scientific | Q1 | 2024 | $0.50 | $0.52 | $0.52 | $3.64B | $3.71B | $3.67B | Get Alert |
| 10/26/2023 | BSX | Boston Scientific | FY | 2023 | $1.99 | $2.02 | $2.00 | $14.08B | $14.08B | $14.09B | Get Alert |
| 10/26/2023 | BSX | Boston Scientific | Q4 | 2023 | $0.49 | $0.52 | $0.52 | $3.53B | $3.60B | $3.63B | Get Alert |
| 09/20/2023 | BSX | Boston Scientific | FY | 2023 | $1.96 | $2.00 | $1.99 | $14.00B | $14.00B | $14.09B | Get Alert |
| 07/27/2023 | BSX | Boston Scientific | FY | 2023 | $1.96 | $2.00 | $1.95 | $14.01B | $14.14B | $13.95B | Get Alert |
| 07/27/2023 | BSX | Boston Scientific | Q3 | 2023 | $0.46 | $0.48 | $0.48 | $3.44B | $3.50B | $3.44B | Get Alert |
| 04/26/2023 | BSX | Boston Scientific | FY | 2023 | $1.90 | $1.96 | $1.91 | $13.76B | $14.01B | $13.55B | Get Alert |
| 04/26/2023 | BSX | Boston Scientific | Q2 | 2023 | $0.48 | $0.50 | $0.48 | $3.46B | $3.52B | $3.44B | Get Alert |
| 02/01/2023 | BSX | Boston Scientific | FY | 2023 | $1.86 | $1.93 | $1.93 | $13.32B | $13.57B | $13.46B | Get Alert |
| 02/01/2023 | BSX | Boston Scientific | Q1 | 2023 | $0.42 | $0.44 | $0.44 | $3.12B | $3.18B | $3.17B | Get Alert |
| 10/26/2022 | BSX | Boston Scientific | FY | 2022 | $1.71 | $1.74 | $1.76 | $12.66B | $12.66B | $12.71B | Get Alert |
| 10/26/2022 | BSX | Boston Scientific | Q4 | 2022 | $0.45 | $0.48 | $0.49 | $3.19B | $3.25B | $3.32B | Get Alert |
| 07/27/2022 | BSX | Boston Scientific | FY | 2022 | $1.74 | $1.77 | $1.76 | $12.66B | $12.78B | $12.82B | Get Alert |
| 07/27/2022 | BSX | Boston Scientific | Q3 | 2022 | $0.43 | $0.45 | $0.45 | $3.11B | $3.17B | $3.20B | Get Alert |
| 04/27/2022 | BSX | Boston Scientific | FY | 2022 | $1.74 | $1.79 | $1.77 | $12.72B | $12.96B | $12.84B | Get Alert |
| 04/27/2022 | BSX | Boston Scientific | Q2 | 2022 | $0.41 | $0.43 | $0.44 | $3.17B | $3.26B | $3.27B | Get Alert |
| 02/02/2022 | BSX | Boston Scientific | FY | 2022 | $1.73 | $1.79 | $1.87 | $12.60B | $12.84B | $12.93B | Get Alert |
| 02/02/2022 | BSX | Boston Scientific | Q1 | 2022 | $0.38 | $0.40 | $0.41 | $2.89B | $2.97B | $3.03B | Get Alert |
| 10/27/2021 | BSX | Boston Scientific | Q4 | 2021 | $0.43 | $0.45 | $0.44 | $3.06B | $3.17B | $3.20B | Get Alert |
| 10/27/2021 | BSX | Boston Scientific | FY | 2021 | $1.60 | $1.62 | $1.61 | $11.80B | $11.90B | $12.00B | Get Alert |
| 09/22/2021 | BSX | Boston Scientific | FY | 2021 | $1.58 | $1.62 | $1.61 | $12.00B | $12.00B | $12.01B | Get Alert |
| 07/27/2021 | BSX | Boston Scientific | Q3 | 2021 | $0.39 | $0.41 | $0.40 | $2.98B | $3.03B | $2.97B | Get Alert |
| 07/27/2021 | BSX | Boston Scientific | FY | 2021 | $1.58 | $1.62 | $1.58 | $11.99B | $12.09B | $11.75B | Get Alert |
| 04/28/2021 | BSX | Boston Scientific | Q2 | 2021 | $0.36 | $0.38 | $0.35 | $2.92B | $3.00B | $2.76B | Get Alert |
| 04/28/2021 | BSX | Boston Scientific | FY | 2021 | $1.53 | $1.60 | $1.54 | $11.50B | $11.80B | $11.43B | Get Alert |
| 02/03/2021 | BSX | Boston Scientific | Q1 | 2021 | $0.28 | $0.34 | $0.35 | $2.54B | $2.70B | $2.73B | Get Alert |
| 02/03/2021 | BSX | Boston Scientific | FY | 2021 | $1.50 | $1.60 | $1.62 | $11.20B | $11.80B | $11.53B | Get Alert |
| 01/12/2021 | BSX | Boston Scientific | FY | 2020 | — | — | — | $9.91B | $9.91B | $10.08B | Get Alert |
| 01/12/2021 | BSX | Boston Scientific | Q4 | 2020 | — | — | — | $2.71B | $2.71B | $2.86B | Get Alert |
FAQ
What is the most recent guidance for Boston Scientific (BSX)?
The most recent guidance for Boston Scientific (BSX) was reported on April 23, 2025 for Q2 2025. The company provided earnings per share guidance in the range of $0.71 to $0.73, compared to the estimated EPS of $0.71. Additionally, Boston Scientific forecasted revenue between $4.84B and $4.92B for the quarter.
Browse guidance and forecast on all stocks.
